Kenpaullone
GSK3Beta, CDK2 and LCK Inhibitor
Product Specifications
Background
Kenpaullone is a potent inhibitor of CK1 and CDK2, and slightly less on CDK5, by competitive inhibition of adenosine triphosphate (ATP) binding. It is also useful as an inhibitor of GSK3Beta.
CAS Number
142273-20-9
Product Name Alternative
9-Bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6 (5H) -one; NSC-664704
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cell Signaling | Protein Phosphorylation | Cdks| Serine / Threonine Kinases | Cancer | Apoptosis
Purity
>98% (HPLC) ; NMR (Conforms)
Weight
0.005
Format
Beige powder
Solubility
May be dissolved in DMSO (35 mg/ml)
Molecular Formula
C16H11BrN2O
Molecular Weight
327.2
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/kenpaullone
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401022-100 1x 100 µL
Hepatocyte Specific (CPS1/1022), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
